Cece wrote:
...capillaries' endothelium across which the glucose must be transported into the brain can be affected by the conditions caused by the outflow obstructions and this can reduce the transfer of glucose to the brain. But this is hypothetical.
I don't think it's hypothetical when Dr. Zivadinov found in CCSVI patients a shortage of capillaries altogether. They might have died of glucose starvation, or low oxygen, or both. They're definitely gone. I think this may be one of the reasons MN-166 has an effect, reducing axonal loss. It is used for cerebra-vascular treatment, possibly resulting in protection against this loss. Having seen the abundance of holes in my head, that is one reason I am considering re-treatment for CCSVI. I also benefited in the area of autonomous function, although I would have liked to see some return of my breath and singing voice, and my heart did not noticeably improve. Hope my stents stay patent...